ERIKA B-CURE LASER LTD Financials Erika B-Cure Laser Ltd
Equities
BCUR
IL0011789125
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.2 ILa | +5.23% |
|
-10.80% | +0.62% |
| 30/04 | Erika B-Cure Laser Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Erika B-Cure Laser Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 470.1 | 20.94 | 33.33 |
| Enterprise Value (EV) 1 | 428.2 | 11.75 | 27.72 |
| P/E ratio | -47.8 x | -0.47 x | -1.73 x |
| Yield | - | - | - |
| Capitalization / Revenue | 4.46 x | 0.42 x | 1.12 x |
| EV / Revenue | 4.46 x | 0.42 x | 1.12 x |
| EV / EBITDA | -75.7 x | -0.52 x | -1.86 x |
| EV / FCF | -2,25,86,714 x | -8,29,296 x | -2,18,25,430 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 5.34 x | 0.48 x | 1.4 x |
| Nbr of stocks (in thousands) | 1,03,541 | 1,06,309 | 1,04,165 |
| Reference price 2 | 4.540 | 0.1970 | 0.3200 |
| Announcement Date | 30/03/22 | 31/03/23 | 30/04/24 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 35.52 | 50.83 | 85.77 | 105.5 | 49.5 | 29.88 |
| EBITDA 1 | 5.004 | 4.822 | 17.81 | -6.21 | -39.93 | -17.93 |
| EBIT 1 | 4.051 | 4.54 | 17.44 | -6.697 | -40.58 | -20.12 |
| Operating Margin | 11.41% | 8.93% | 20.33% | -6.35% | -81.98% | -67.33% |
| Earnings before Tax (EBT) 1 | 3.451 | 3.729 | 16.7 | -9.664 | -42.64 | -19.22 |
| Net income 1 | 2.537 | 2.343 | 12.46 | -9.692 | -44.02 | -19.22 |
| Net margin | 7.14% | 4.61% | 14.53% | -9.19% | -88.93% | -64.32% |
| EPS 2 | 0.0340 | 0.0283 | 0.1481 | -0.0950 | -0.4230 | -0.1850 |
| Free Cash Flow | - | - | 18.66 | -20.81 | -25.25 | -1.527 |
| FCF margin | - | - | 21.75% | -19.72% | -51.02% | -5.11% |
| FCF Conversion (EBITDA) | - | - | 104.74% | - | - | - |
| FCF Conversion (Net income) | - | - | 149.7% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19/05/21 | 19/05/21 | 19/05/21 | 30/03/22 | 31/03/23 | 30/04/24 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt | - | 9.58 | 4.13 | - | - | - |
| Net Cash position | - | - | - | 41.9 | 9.19 | 5.61 |
| Leverage (Debt/EBITDA) | - | 1.986 x | 0.2319 x | - | - | - |
| Free Cash Flow | - | - | 18.7 | -20.8 | -25.3 | -1.53 |
| ROE (net income / shareholders' equity) | - | - | 206% | -20% | -67.4% | -57.9% |
| ROA (Net income/ Total Assets) | - | - | 29.6% | -4.84% | -26.2% | -21.8% |
| Assets 1 | - | - | 42.17 | 200.1 | 167.9 | 88.12 |
| Book Value Per Share | - | 0.0400 | 0.1100 | 0.8500 | 0.4100 | 0.2300 |
| Cash Flow per Share | - | 0.0700 | 0.1800 | 0.6000 | 0.0700 | 0.0200 |
| Capex 1 | 0.8 | 0.74 | 0.94 | 1.09 | 0.73 | 0.27 |
| Capex / Sales | 2.25% | 1.46% | 1.1% | 1.03% | 1.48% | 0.92% |
| Announcement Date | 19/05/21 | 19/05/21 | 19/05/21 | 30/03/22 | 31/03/23 | 30/04/24 |
1ILS in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +0.62% | 8.67M | |
| +2.56% | 867M | |
| -23.38% | 257M | |
| -37.78% | 74.06M |
- Stock Market
- Equities
- BCUR Stock
- Financials Erika B-Cure Laser Ltd
